Introduction {#sec1}
============

Insect ovaries undergo periodic changes during the course of their development. Polytrophic ovaries of flies pass through 14 developmental stages based on the deposition of yolk in their oocytes ([@bibr20]). From the 1^st^ to the 6^th^ stage they contain no yolk; in stages 7--10 the growing oocytes continuously fill with yolk filling up to half of the egg chamber volume. In this process, the follicular cells that form a single layer surrounding the oocyte and nutritive cells play an important role. Nutrients (proteins, peptides, lipidic substances, and carbohydrates) are synthesized and stored in the fat body from which they are transported to the growing ovaries by the hemolymph. During previtellogenesis, the tightly packed cells of the follicular epithelium shrink under hormonal influence ([@bibr23]; [@bibr08]; [@bibr21]) and form intercellular spaces where cytoskeletal structures and protuberancies appear ([@bibr25]; [@bibr14]). This patency of follicular cells enables the transport of nutrients to the growing oocyte and takes part in the synthesis of yolk components in the oocyte cytoplasm ([@bibr18]; [@bibr19]; [@bibr06]; [@bibr13]). The activity of follicular cells may vary with the demand of particular nutrients by the oocyte during a reproductive cycle ([@bibr09]).

A study using the trypsin modulating oostatic factor (TMOF) of the mosquito, *Aedes aegypti* L. (Diptera: Culicidae), and the flesh fly, *Neobellieria bullata* (Parker) (Diptera: Sarcophagidae), for the investigation of their sterilizing effect on a partly autogenous strain of *N. bullata* had negative results, and, consequently, a new study was done of peptides with the C-terminal shortened sequence of Aed-TMOF (H-Tyr-Asp-Pro-Ala-PrO6-OH; [@bibr04], [@bibr05]). The evaluation of morphological changes was done on the structures of the first and second egg chambers of *N. bullata* during the reproductive cycle. The greatest effects on developing ovaries were found after injection of the respective pentapeptide 5P (H-Tyr-Asp-Pro-Ala-Pro-OH) or tetrapeptide 4P (H-Tyr-Asp-Pro-Ala-OH) ([@bibr24]). In studies of the effects of 5P on vitellogenic stages ([@bibr15], [@bibr16]; [@bibr03]; [@bibr24]) differences were found between morphological changes of both egg chambers: in the first one there were no visible effects, while in the second, proliferation of the follicular epithelium into the inner space of egg chamber, followed by resorption was observed ([Figure 1](#f01){ref-type="fig"}). Therefore, its ^3^H-labeled forms were used for further studies on radioactivity accumulation and degradation of the oostatic peptides in the flesh fly *N. bullata* and other insects ([@bibr26], [@bibr29]; [@bibr24]; [@bibr17]). On the other hand, the native TMOF of *N. bullata*, hexapeptide H-Asn-Pro-Thr-Asn-Leu-His-OH ([@bibr07]; [@bibr11]), has no structural similarity to the above oostatic peptides and lacks any oostatic effects, nor does its isosteric analogue H-Asn-Proψ\[CH~2~O\]-D-Thr-Asn-Leu-His-OH, (Bennettová, unpublished results; Hlaváček et al. 2004). Oostatic peptides represent an effective tool for insect control by inhibiting egg development ([@bibr24]; [@bibr29]).

Relative to other biologically active substances (e.g. pesticides, fungicides or juvenogens), oostatic peptides are relatively simple to synthesize and have no negative environmental impact ([@bibr27]). They are also soluble in water. However, their mode of action is not understood.

In this study, the uptake of an *in vivo* injected oostatic pentapeptide (5P) into ovaries of *N. bullata* was estimated at different stages of vitellogenesis (7--10) using radiolabeled peptide. Isolated ovaries were also incubated with radiolabeled peptide *in vitro.* The radioactive metabolites in the ovaries after *in vivo* and *in vitro* uptake of radiolabeled peptide were compared.

Materials and Methods {#sec2}
=====================

Radiolabeled peptide and developmental stages {#sec2a}
---------------------------------------------

Tritiated oostatic pentapeptide (5P) H-Tyr-Asp-\[^3^H\]Pro-Ala-Pro-OH, \[^3^HPrO^3^\] 5P, 1.44TBq/mmol, with radiochemical purity \> 98%, as described earlier Hlaváček et al. ([@bibr17]) was used in the study. Different stages of yolk deposition were classified according to the scale developed by King ([@bibr20]). For *in vivo* applications the ovaries were divided into 2 groups (one with eggs in the 7^th^ and 8^th^ stages of development and the second with eggs in the 9^th^ and 10^th^ stages of development). For the experiments *in vitro*, each of these four tested stages of egg development were evaluated individually.

![Histology of degenerative changes in the flesh fly *Neobellieria bullata* ovaries after application of oostatic pentapeptide (5P). A: Normal ovary development. B: The inner space of egg chamber filled up with nuclei and cells that originated from follicular epithelium. High quality figures are available online.](f01_01){#f01}

*In vivo* experiments {#sec2b}
---------------------

\[^3^HPro^3^\]5P was injected in 5 µl (37 kBq) of physiological solution into left upper part of the thoraces of ether-anesthetized female *N. bullata*. Flies were then dissected at given time intervals, and 12 pairs of ovaries of the same developmental stage (7, 8, 9 and 10) were selected for each interval. Each pair of ovaries was placed into a separate scintillation vial and covered with 0.5 ml of tissue solubilizer (NCS II, Amersham International, [www.gelifesciences.com](www.gelifesciences.com)). After six days, 10 ml of liquid scintillator EcoLite (ICN Biochemicals Inc.) were added and the radioactivity determined in the spectrometer Beckman 6500. The highest and lowest values of the sets were eliminated and the 10 remaining samples were used for evaluation of the mean values and their standard deviations. Three such experiments were carried out independently and from all of them the total mean values with their standard deviations (from ± 16% to ± 25%) were calculated. For metabolite determination by radio-HPLC, in each time interval 10--15 pairs of ovaries were dissected from the injected *N. Bullata*, pooled into groups according to developmental stage and frozen at -70° C until extraction.

*In vitro* experiments {#sec2c}
----------------------

Twelve dissected pairs of ovaries of identical stage and appearance were placed into a solution of \[^3^HPro^3^\]5P (555 kBq in 450 µl of physiological solution) in small embryo dishes at room temperature. At time periods equal to those for the *in vivo* experiments, the ovaries were removed, washed twice in physiological solution, and each pair was placed into individual scintillation vials for determination of total radioactivity and treated as described for the *in vivo* experiment. From three independent experiments, the total S.D. was calculated from ± 13% to ± 24%. Simultaneously, incubation for the selected time period was done for metabolite determination, and the sample was frozen as for the *in vivo* experiments.

Extraction for metabolite determination {#sec2d}
---------------------------------------

An ice-cold solution (0.4 ml) of protease inhibitor cocktail Complete Mini (Roche Applied Sciences, [www.roche-applied-science.com](www.roche-applied-science.com)) (1 tablet dissolved in 3.5 ml of 50 mM HEPES buffer pH 7.6) was added to the frozen pooled ovaries in an Eppendorf tube, and the contents were homogenized for 1 min using a Teflon pestel. After centrifugation, the supernatant was removed and either immediately analyzed by radio-HPLC or frozen and analyzed later.

Analysis of 5P metabolites {#sec2e}
--------------------------

All radio-HPLC analyses were performed using a Waters liquid Chromatograph (Waters, [www.waters.com](www.waters.com)). A programmable UV detector was connected on-line to a radiometric flow-through detection system (Beckman 171, [www.beckman.com](www.beckman.com)). The stainless steel analytical column (250 × 4 mm) LiChroCART (Merck, [www.merck.com](www.merck.com)), packed with LiChrosphere WP-300, with a particle size of 5 µm was used. The column was protected with a (4 mm × 4 mm) guard column packed with LiChrosphere 100 RP-18, particle size 5 µm (Merck). The mobile phase was composed of the aqueous phase (0.035% TFA in redistilled water) and the organic phase (0.05% in acetonitrile). After passing through the UV detector, the eluent was continuously mixed with the liquid scintillator Ready Safe (Beckman Coulter) with a ratio of 1:2.5 (v/v) in an on-line mixer. The mixture was run through a 500 µl detection cell. The radiometric detector threshold was set at 0.02%. The UV detector was set at 230 nm, 0.05 AUFS. Separation was performed at ambient temperature using a 30 min linear gradient from 0% to 30% organic phase using a flow rate of 0.8 m1/min and continuous degassing with helium. A sample volume of 20 to 80 µl was used. The area of each peak was evaluated as the ratio of its counting rate to the totally measured counting rate in all peaks of the appropriate radiochromatogram (relative concentration crel in percentage). The stability of the \[^3^HPro^3^\]5P was checked before each experiment.

Samples were centrifuged for 5 min, and an aliquot of the supernatant was analyzed. Standard unlabeled peptides ([@bibr17]) as well as non-active proline were detected by UV, and their retention times were compared to that of the peaks in the radiochromatogram. The retention times of radioactive fractions were corrected to the time delay between the UV and the radiometric detector (0.55 min). The precision of the method was expressed as the coefficient of variation in percentage that varied from 1.3 to 7.7%). It was determined by analyzing five replicates of the same biological sample within one day.

The extraction procedure recovery was evaluated using \[^3^HPro^3^\]5P calibration solutions of three different concentrations (42, 150 and 370 kBq/ml) by comparison of the extracted and the applied radioactivity. The average recovery was between 86.6% and 97.2% (*n* = 4) with precision range from 3.3 to 5.2 (% coefficient of variation). The linearity of the radiometric detector response was verified using \[^3^HPro^3^\]5P calibration solutions in the range of 0.2--10 kBq with an average correlation coefficient of 0.997 (*n* = 4). The absolute detection limit in the system, defined by a signal-to-noise ratio of 3, was assigned for the 5P in the range of 85--150 Bq that corresponds to 59--104 (rounded 60--100) fmol.

![Radioactivity of ovaries in different vitellogenic stages of development in dependence on time after application *in vivo* (1, 2) or *in vitro* (3--6). Stage of development according to King ([@bibr20]): 1: 7th and 8th; 2: 9th and 10th; 3; 7th; 4: 8th; 5: 9th; 6: 10th. Sets of 10 samples in 3 independent experiments were evaluated for each point, S.D. of the presented means from ± 16% to ± 25%. High quality figures are available online.](f02_01){#f02}

Results and Discussion {#sec3}
======================

In this study, attention was focused on the uptake of the oostatic pentapeptide 5P (H-Tyr-Asp-Pro-Ala-Pro-OH) by ovaries of *N. bullata*. As a continuation of previous studies ([@bibr29]), the uptake was monitored in relation to the stage of egg development (vitellogenesis or yolk deposition) and tested *in vitro*. The total radioactivity in the ovaries ([Figure 2](#f02){ref-type="fig"}) was determined, and the radioactive components in extracts of ovaries were analyzed. Radiolabeled metabolites of \[^3^H-Pro^3^\]5P found in ovaries were identified using synthetic standards of non-labeled sequences ([@bibr17]) as illustrated in [Figure 3](#f03){ref-type="fig"}.

As can be seen in [Figure 2](#f02){ref-type="fig"}, the time course of radioactivity uptake was different for *in vitro* and *in vivo* experiments. In the latter case, the radioactivity increased until 10 min after application, then decreased, and after 30 min it was almost constant. No statistically significant differences were found between the two experimental groups (curves 1 and 2 in [Figure 2](#f02){ref-type="fig"}). Such a time coarse could be explained by a single injection of \[^3^HPro^3^\]5P. On the contrary, for the *in vitro* experiments, radioactivity continuously increased because there was permanent contact of 5P with the ovaries. Nevertheless, there were statistically significant differences between the two following groups. With small yolk deposition ([Figure 2](#f02){ref-type="fig"}, curves 3 and 4), the radioactivity increased slowly and continuously during the measured time interval. In the later developmental stages ([Figure 2](#f02){ref-type="fig"}, curves 5 and 6), a rapid increase was found until 30 min, at which time the radioactivity was practically continuous, which was similar to the results of the *in vivo* experiment. In this time interval of practically stable radioactivity, the concentration of the 5P metabolites seemed to reach its maximum.

![Lower; radiochromatogram of an extract of ovaries of the 10th stage 5 min after \[^3^HPro^3^\]5P *in vitro* application; Upper; chromatogram of non-active standards. High quality figures are available online.](f03_01){#f03}

Independently of application method, the metabolites were qualitatively identical, and no 5P was found by 30 s after application ([Table 1](#t01){ref-type="table"}). This finding suggests an effective enzymatic system for peptide degradation. Such system may be located in the interfollicular spaces once their patency was evoked by a juvenile hormone or some other hormonal action ([@bibr08]), on the oocyte membrane adjacent to the apical part of the follicular cells ([@bibr25]), or possibly in the oocyte cytoplasm. The process of follicular cell patency is finished prior to the onset of vitellogenesis ([@bibr25]). The active peptide intake increases with continuous yolk deposition even though a receptor responsible for oostatic peptide transport was not previously found ([@bibr24]).

Regarding the metabolites, the composition of radioactive substances was qualitatively almost identical during the entire period followed (30 s-180 min), both after incubation with the peptide *in vitro* and also after administration of the peptide *in vivo*. As can be seen in [Table 1](#t01){ref-type="table"}, there was a very rapid degradation of the 5P, which was not detectable in either case after 30 s. The same results were found for all tested stages during egg development. These results suggest that there is an extremely rapid metabolic cleavage of the N-terminal Tyr^1^, and the remaining 4P (H-Asp-\[^3^H\]Pro-Ala-Pro-OH) probably is then degraded into two dipeptides from which H-Asp-\[^3^HPro\]-OH then gives rise very quickly to \[^3^H\]Pro.

###### 

Metabolites of \[^3^H- Pro^3^\]SP in ovaries of stage 10 in % of total radioactivity

![](t01_01)

The differences between the *in vivo* and *in vitro* experiments may be explained by the partly metabolized 5P (*in vivo*), which is incorporated into the fat body. Then, as with other nutrients, it is delivered by hemolymph to the ovaries ([@bibr27]). On the contrary, the *in vitro* intake of non-metabolized 5P begins in the incubated ovaries, where only the 5P alone is available and the metabolism of ovaries takes place without any nutrient.

Very interesting is the fact that isolated ovaries with no connection to the tracheal system, the nervous system and/or the hemolymph were still able to use the 5P by a way other than simple diffusion and and to metabolize it to qualitatively identical metabolites as occured in intact ovaries. Previous studies revealed rich innervation of ovaries by branches of the median nerve that originate in thoracic ganglium, and, via the lateral oviduct, innervate each ovariole along the ovarian sheath ([@bibr01]). Neurosecretory cells were located in close connection with follicular cells and granules of neurosecretory material were present ([@bibr02]). Such findings might be responsible for the independent functioning of ovaries *in vitro*, at least for a limited amount of time.

Conclusions {#sec3a}
-----------

These results showed that the uptake of the oostatic 5P metabolites into the ovaries of *N. bullata* depended on the stage of the vitellogenic ovaries. Unlike the case after *in vivo* injection, the *in vitro* experiments show that ovaries that have low amounts of yolk also accumulate the metabolites at a slower rate. On the other hand, in later vitellogenic stages radioactivity quickly reached a maximum and then stayed almost constant, which was similar to the *in vivo* assay. In all tested ovaries, no 5P was found by 30 s after application, and the same 5P radiometabolites were detected. The results of these analyses of \[^3^HPro\]5P and its metabolites seem to point towards the existence of an enzymatic system that very effectively degrades the 5P TMOF analogue during the transport into the egg chamber. An active intake of the analyzed sequences into the intercellular spaces between follicular cells may be assumed.

The study was performed as project No. 203/06/1272 of the Czech Science Foundation and project Z4 055 0506 of the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic.
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